AbCellera Biologics Inc. - Ordinary Shares (ABCL)

CUSIP: 00288U106

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Equity / Ordinary Shares
Shares outstanding
293,061,432
Total 13F shares
113,127,329
Share change
-1,221,415
Total reported value
$1,100,172,856
Put/Call ratio
31%
Price per share
$9.75
Number of holders
126
Value change
-$30,931,776
Number of buys
67
Number of sells
54

Quarterly Holders Quick Answers

What is CUSIP 00288U106?
CUSIP 00288U106 identifies ABCL - AbCellera Biologics Inc. - Ordinary Shares in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of AbCellera Biologics Inc. - Ordinary Shares (ABCL) as of Q1 2022

As of 31 Mar 2022, AbCellera Biologics Inc. - Ordinary Shares (ABCL) was held by 126 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 113,127,329 shares. The largest 10 holders included Capital World Investors, Allianz Asset Management GmbH, BAILLIE GIFFORD & CO, BAKER BROS. ADVISORS LP, SB Management Ltd, DCVC Bio GP, LLC, ORBIMED ADVISORS LLC, HARVARD MANAGEMENT CO INC, GUARDIAN CAPITAL ADVISORS LP, and Founders Fund VII Management, LLC. This page lists 126 institutional shareholders reporting positions in this security for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.